Clinical trial
Dipyridamole Assessment for Flare Reduction in SLE
NCT01781611 is registered in ClinicalTrials.gov with Oklahoma Medical Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dipyridamole Assessment for Flare Reduction in SLE
- Lead sponsor
- Oklahoma Medical Research Foundation
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 28, 2013
- Completion date
- November 30, 2017
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus